SomaLogic /
Palamedrix
SomaLogic agrees to combine with Palamedrix in merger transaction
- Price
- $14.0m
- Stage
- Agreement signed
What happened
SomaLogic, Inc. entered into an agreement to merge with Palamedrix, Inc. on July 25, 2022. Palamedrix will become a wholly owned subsidiary of SomaLogic following the mergers.
The upfront consideration includes approximately $14.0 million in cash and $21.0 million in SomaLogic common stock. Certain Palamedrix securityholders may also receive up to an additional $17.5 million in milestone payments.
The source
Everything on this page comes from the source below.
SomaLogic agrees to combine with Palamedrix in merger transaction
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Also stated
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly